Reported 1,654,156 shares, up 1,128,676 (214.8%) from the prior quarter.
Reported value 126.4%; share count 214.8% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 5280000 |
| 2021-12-31 | 2623000 |
| 2022-03-31 | 5939000 |
| 2022-06-30 | 4717000 |
| 2022-09-30 | 2228000 |
| 2022-12-31 | 1961669 |
| 2023-03-31 | 425395 |
| 2023-06-30 | 168186 |
| 2023-09-30 | 118349 |
| 2023-12-31 | 276265 |
| 2024-03-31 | 0 |
| 2024-03-31 | 955971 |
| 2024-06-30 | 837946 |
| 2024-09-30 | 549863 |
| 2024-12-31 | 243898 |
| 2025-03-31 | 463970 |
| 2025-06-30 | 817792 |
| 2025-09-30 | 1841053 |
| 2025-12-31 | 184142 |
| 2026-03-31 | 111125 |
| 2026-06-30 | 55283 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 50,256 | -13,608 (-21.3%) | < 0.01% | $55,283 | 2026-08-13 | |
| Q1 2026 | Reduced | 63,864 | -41,964 (-39.7%) | < 0.01% | $111,125 | 2026-05-15 | |
| Q4 2025 | Reduced | 105,828 | -680,946 (-86.5%) | < 0.01% | $184,142 | 2026-02-13 | |
| Q3 2025 | Added | 786,774 | +384,912 (95.8%) | < 0.01% | $1,841,053 | 2025-11-14 | |
| Q2 2025 | Added | 401,862 | +117,219 (41.2%) | < 0.01% | $817,792 | 2025-08-15 | |
| Q1 2025 | Added | 284,643 | +151,366 (113.6%) | < 0.01% | $463,970 | 2025-05-15 | |
| Q4 2024 | Added | 133,277 | +38,145 (40.1%) | < 0.01% | $243,898 | 2025-02-14 | |
| Q3 2024 | Reduced | 95,132 | -8,574 (-8.3%) | < 0.01% | $549,863 | 2024-11-14 | |
| Q2 2024 | Added | 103,706 | +34,832 (50.6%) | < 0.01% | $837,946 | 2024-08-14 | |
| Q1 2024 | New | 68,874 | +68,874 (0.0%) | < 0.01% | $955,971 | 2024-05-15 | |
| Q1 2024 | Reduced | 0 | -541,696 (-100.0%) | 0 | $0 | 2024-05-15 | |
| Q4 2023 | Added | 541,696 | +237,459 (78.1%) | < 0.01% | $276,265 | 2024-02-13 | |
| Q3 2023 | Reduced | 304,237 | -72,440 (-19.2%) | < 0.01% | $118,349 | 2023-11-15 | |
| Q2 2023 | Reduced | 376,677 | -142,099 (-27.4%) | < 0.01% | $168,186 | 2023-08-14 | |
| Q1 2023 | Reduced | 518,776 | -738,703 (-58.7%) | < 0.01% | $425,395 | 2023-05-15 | |
| Q4 2022 | Reduced | 1,257,479 | -34,765 (-2.7%) | < 0.01% | $1,961,669 | 2023-02-14 | |
| Q3 2022 | Reduced | 1,292,244 | -1,434,139 (-52.6%) | < 0.01% | $2,228,000 | 2022-11-14 | |
| Q2 2022 | Added | 2,726,383 | +1,072,227 (64.8%) | < 0.01% | $4,717,000 | 2022-08-15 | |
| Q1 2022 | Added | 1,654,156 | +1,128,676 (214.8%) | < 0.01% | $5,939,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 525,480 | -211,906 (-28.7%) | < 0.01% | $2,623,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 737,386 | -92,674 (-11.2%) | < 0.01% | $5,280,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
226 managers reported INOVIO PHARMACEUTICALS, INC. N for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | Added | 23,267,928 | +9,967,498 | < 0.01% | $83,532,000 | 32 qtrs |
| BlackRock Inc | Reduced | 18,046,901 | -198,013 | < 0.01% | $64,788,000 | 32 qtrs |
| VANGUARD GROUP INC | Added | 11,247,922 | +208,609 | < 0.01% | $40,381,000 | 32 qtrs |
| D E Shaw & Co Inc | Reduced | 5,499,823 | -485,710 | 0.02% | $19,744,000 | 30 qtrs |
| JPMorgan Chase & Co | Reduced | 3,440,819 | -357,059 | < 0.01% | $12,352,000 | 31 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 3,393,033 | -281,593 | < 0.01% | $12,180,000 | 32 qtrs |
| TWO SIGMA INVESTMENTS LP | New | 2,338,415 | +2,338,415 | 0.02% | $8,395,000 | 1 qtr |
| Rafferty Asset Management LLC | Added | 1,979,825 | +747,754 | 0.04% | $7,108,000 | 8 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 1,891,847 | -74,081 | < 0.01% | $6,792,000 | 32 qtrs |
| MORGAN STANLEY This report | Added | 1,654,156 | +1,128,676 | < 0.01% | $5,939,000 | 32 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- May 13, 2022
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 1,584,731
- Shared
- 4,430
- None
- 64,995
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.